NEW YORK (360Dx) – Under a recent Centers for Disease Control and Prevention contract, Rutgers University is validating PCR and real-time PCR assays that could one day be used by hospitals to quickly identify Candida auris, an emerging multidrug-resistant fungal pathogen.

The pathogen is difficult to identity, often does not respond to antifungal drugs, and causes invasive infections that are often acquired in hospitals and are associated with high mortality in patients.